Covered recipient · General Payments record
SARA RAAFAT GHOBRAIEL
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$4,262.13
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,002.30 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $572.18 | 6 |
| Bausch & Lomb Americas Inc. | $143.93 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $122.30 | 1 |
| ABBVIE INC. | $111.14 | 4 |
| Alcon Laboratories Inc | $38.61 | 2 |
| Sight Sciences, Inc. | $14.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.81 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103793379 | CMS |
| ABBVIE INC. | $29.10 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103793381 | CMS |
| ABBVIE INC. | $28.72 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103793383 | CMS |
| ABBVIE INC. | $25.51 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103793385 | CMS |
| Alcon Vision LLC | $19.40 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700370 | CMS |
| Alcon Vision LLC | $19.21 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700368 | CMS |
| Bausch & Lomb Americas Inc. | $24.26 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140443682 | CMS |
| Bausch & Lomb Americas Inc. | $15.89 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140443678 | CMS |
| Bausch & Lomb Americas Inc. | $103.78 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140443680 | CMS |
| Glaukos Corporation | $191.15 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151978162 | CMS |
| Glaukos Corporation | $117.17 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151982072 | CMS |
| Glaukos Corporation | $4.25 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151982066 | CMS |
| Glaukos Corporation | $73.08 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151982070 | CMS |
| Glaukos Corporation | $28.53 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151982068 | CMS |
| Glaukos Corporation | $158.00 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151978160 | CMS |
| Sight Sciences, Inc. | $14.14 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151930653 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $122.30 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152199435 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.